Novartis CEO sees IRA impact ‘manageable’ in short run, maintains midterm growth goal 18.07.2024 18:08 Fiercepharma.com Novartis CEO sees IRA impact ‘manageable’ in short run, maintains midterm growth goal aliu Thu, 07/18/2024 - 11:08
